Free discreet shipping across the EU · dispatch within 24 hCOA per batch · ≥99% HPLC
Research area

Peptides and cognition research

This is the area where the gap between what is claimed and what has been independently replicated is widest. Much of the underlying work was published in Russian, and a lot of it has never been repeated elsewhere. That is not a reason to ignore it, but it is a reason to say so.

ISO-certified laboratoryCOA per batch, ≥99%Discreet 24h dispatchResearch use only
The mechanism

A short literature, honestly described

The compounds studied here are short sequences, several of them derived from fragments of larger signalling molecules. The proposed mechanisms usually involve neurotrophic factors or neurotransmitter regulation, and most of the evidence sits in animal models and small human studies from a single research tradition.

Two practical things follow from that. First, replication outside the original groups is limited, so a confident-sounding summary online is usually reporting one study rather than a body of work. Second, translation quality varies, and details get lost between the original paper and the English summary that circulates.

The nasal route appears more often here than anywhere else in the catalogue, and that is not coincidental: these are among the few sequences short enough for the mucosal route to be worth studying at all.

What is being investigated
  • Neurotrophic factor expression in animal models
  • Neurotransmitter regulation and receptor interaction
  • Why so much of the source literature is Russian-language
  • Chain length and why the nasal route appears here

Where this sits legally

None of these compounds holds an approval in the EU. Some are used clinically in other jurisdictions under different regulatory systems, which is not the same thing and should not be read as one.

In this area

Compounds studied here

Five items, several available in both pen and spray so routes can be compared.

Where we stop

What this page leaves out

We do not use the word nootropic, because it implies a demonstrated effect in people that this literature has not established. We also flag where source material is hard to verify rather than quietly citing a summary of a summary. That leaves less to say than most pages on this subject, which is the point.

Frequently asked

Questions about this area

Often about how to read a study you can only find in summary.

Why does it matter that the research is Russian-language?
Not because of where it was done, but because of what follows: less independent replication outside the original groups, and summaries that pass through translation before they reach you. Both make it harder to check a claim against its source, which is the thing that actually matters.
Are these compounds nootropics?
That word does a lot of work it has not earned. It implies a demonstrated effect on cognition in people, which is exactly what this literature does not establish. We describe them as compounds studied in neuropeptide research, because that is what they are.
Why are Semax and Selank available as both pen and spray?
Because both routes appear in the literature and researchers ask for both. Which one suits your work depends on what you are comparing; the format comparison sets out the trade-offs.
Is Dihexa a peptide?
No. It is a small molecule derived from angiotensin IV. It sits in this area because of the research question rather than the chemistry, and the individual file is explicit about that.
How should I read a study I can only find in summary?
With scepticism about the summary rather than the study. If you cannot get to the original method section, you do not know what was measured, in what model, at what exposure. That is not a small gap.
Before you order

Thin evidence, stated plainly

We would rather tell you a literature is limited than dress it up. What we can prove is what is in the vial, and that part is on paper.

For laboratory and research use only. Not for human or animal consumption. Not a medicine and not a food supplement. Sold to persons aged 18 and over. Compounds named on this page may appear on the WADA prohibited list.

Scroll naar boven